Here, we genetically engineered MCF-7 cells, a model of low-metastatic luminal breast cancer cells that express both ERα and PR transcription factors and whose growth is partly dependent on estrogen supply (17), to artificially modify their epigenome. Here, PGR is linked to breast cancer.